Paul M. Silva

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul M. Silva:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 25,000 19 May 2025 Direct
Rapport Therapeutics, Inc. Director Stock Option (Right to Buy) 10,925 17 Jun 2025 Direct

Insider Reports Filed by Paul M. Silva

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPP Rapport Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:15
NRIX Nurix Therapeutics, Inc. 19 May 2025 1 $0 4 Director 19 May 2025, 17:33
RAPP Rapport Therapeutics, Inc. 07 Nov 2024 1 $0 4 Director 07 Nov 2024, 18:59
RAPP Rapport Therapeutics, Inc. 07 Nov 2024 0 $0 3 Director 07 Nov 2024, 18:35
NRIX Nurix Therapeutics, Inc. 20 May 2024 1 $0 4 Director 20 May 2024, 19:26
NRIX Nurix Therapeutics, Inc. 04 May 2023 1 $0 4 Director 04 May 2023, 20:00
NRIX Nurix Therapeutics, Inc. 05 May 2022 1 $0 4 Director 06 May 2022, 17:44
NRIX Nurix Therapeutics, Inc. 01 Oct 2021 1 $0 4 Director 04 Oct 2021, 17:15
NRIX Nurix Therapeutics, Inc. 01 Oct 2021 0 $0 3 Director 01 Oct 2021, 16:16